Back to Search Start Over

Relationship Between Attenuated Plaque Identified by Intravascular Ultrasound and Thrombus Formation After Excimer Laser Coronary Angioplasty.

Authors :
Nakano T
Ikenaga H
Takeda A
Morita Y
Higashihara T
Watanabe N
Sada Y
Nakano Y
Source :
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2023 Apr; Vol. 49, pp. 15-21. Date of Electronic Publication: 2022 Dec 31.
Publication Year :
2023

Abstract

Background: Excimer laser coronary angioplasty (ELCA) has been reported to be a safe and effective atherectomy device in percutaneous coronary intervention (PCI). However, thrombotic complications after ELCA have been occasionally observed. In this study, we evaluated the impact of attenuated plaque on thrombus formation and transient no-reflow after ELCA.<br />Methods: This study enrolled 58 lesions in 56 patients who underwent PCI with ELCA. It was a retrospective observational study at a single center. All lesions were imaged by intravascular ultrasound (IVUS) before and immediately after ELCA. On the plaque with ultrasound attenuation, attenuation angle per millimeter and attenuation length were measured. ELCA-induced thrombus was detected by IVUS, and transient no-reflow after ELCA was recorded.<br />Results: Thrombus was detected in 14 lesions (30 %), and transient no-reflow occurred in 3 lesions (5 %). Lesions with thrombus had a higher mean attenuation angle (median [interquartile range] 142° [112°-152°] vs. 64° [0°-115°]; p = 0.001), maximum attenuation angle (209° [174°-262°] vs. 86° [0°-173°]; p < 0.001), and longer attenuation length (12 mm [8 mm-17 mm] vs. 2 mm [0 mm-5 mm]; p < 0.001). Lesions with thrombus leading to transient no-reflow had a longer lipid length and a significantly higher troponin I level after PCI.<br />Conclusions: IVUS-identified attenuated plaque was strongly correlated with ELCA-induced thrombus. Furthermore, attenuation length may predict transient no-reflow.<br />Competing Interests: Declaration of competing interest None of the authors have any conflicts of interest or financial relationships related to this study.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-0938
Volume :
49
Database :
MEDLINE
Journal :
Cardiovascular revascularization medicine : including molecular interventions
Publication Type :
Academic Journal
Accession number :
36599747
Full Text :
https://doi.org/10.1016/j.carrev.2022.12.010